Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 3
1999 2
2000 8
2001 4
2002 2
2003 3
2004 5
2005 3
2006 1
2007 3
2008 2
2009 6
2010 8
2011 7
2012 6
2013 6
2014 8
2015 7
2016 8
2017 6
2018 6
2019 5
2020 2
2021 2
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 23077087

100 results

Results by year

Filters applied: . Clear all
Page 1
Memantine for axial signs in Parkinson's disease: a randomised, double-blind, placebo-controlled pilot study.
Moreau C, Delval A, Tiffreau V, Defebvre L, Dujardin K, Duhamel A, Petyt G, Hossein-Foucher C, Blum D, Sablonnière B, Schraen S, Allorge D, Destée A, Bordet R, Devos D. Moreau C, et al. J Neurol Neurosurg Psychiatry. 2013 May;84(5):552-5. doi: 10.1136/jnnp-2012-303182. Epub 2012 Oct 16. J Neurol Neurosurg Psychiatry. 2013. PMID: 23077087 Free PMC article. Clinical Trial.
Safety and efficacy of CVT-301 (levodopa inhalation powder) on motor function during off periods in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled phase 3 trial.
LeWitt PA, Hauser RA, Pahwa R, Isaacson SH, Fernandez HH, Lew M, Saint-Hilaire M, Pourcher E, Lopez-Manzanares L, Waters C, Rudzínska M, Sedkov A, Batycky R, Oh C; SPAN-PD Study Investigators. LeWitt PA, et al. Lancet Neurol. 2019 Feb;18(2):145-154. doi: 10.1016/S1474-4422(18)30405-8. Lancet Neurol. 2019. PMID: 30663606 Clinical Trial.
Rasagiline as an adjunct to levodopa in patients with Parkinson's disease and motor fluctuations (LARGO, Lasting effect in Adjunct therapy with Rasagiline Given Once daily, study): a randomised, double-blind, parallel-group trial.
Rascol O, Brooks DJ, Melamed E, Oertel W, Poewe W, Stocchi F, Tolosa E; LARGO study group. Rascol O, et al. Lancet. 2005 Mar 12-18;365(9463):947-54. doi: 10.1016/S0140-6736(05)71083-7. Lancet. 2005. PMID: 15766996 Clinical Trial.
100 results